Physician profile
Edward Collins
NPI 1144373705
$1,515.94
in general payments reported to CMS, 2019-2025
16 companies · $661 in 2025
The $661 reported for 2025 was more than what 81% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.08 · 2022: $57.21 · 2023: $371 · 2024: $406 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,437.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $495.51 | 2024-2025 | Impella |
| Biosense Webster, INC. | $347.88 | 2022-2024 | Qdot Micro Catheter, Carto 3, Octaray Mapping Catheter |
| Novartis Pharmaceuticals Corporation | $196.55 | 2024-2025 | |
| Terumo Medical Corporation | $95.14 | 2022-2023 | Glidesheath Slender, Glidewire, Angio-Seal |
| E.R. Squibb & Sons, L.L.C. | $70.76 | 2024-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $54.75 | 2024 | Corevalve Evolut R |
| Novo Nordisk INC | $48.43 | 2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.59 | 2024 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $34.26 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $30.77 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $21.08 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.28 | 2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $17.46 | 2025 | Opsumit |
| Abbott Laboratories | $16.95 | 2024 | Diamondback Coronary |
| Amgen INC. | $16.63 | 2025 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.